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 Highlights: 
 First adequately powered, randomized, controlled trial of quantitative information in a 
decision aid. 
 Viewing quantitative information did not reduce intention to be screened or uptake. 
 Viewing quantitative information increased perceived risk of colorectal cancer. 
 Viewing quantitative information increased selection of a non-invasive screening test. 
 
Abstract 
 
Objective:  Guidelines recommend that decision aids provide quantitative information about 
risks and benefits of available options.  Impact of providing this information is unknown. 
 
Methods:  Randomized trial comparing two decision aids about colorectal cancer (CRC) 
screening with colonoscopy or fecal immunochemical test (FIT).   688 primary care patients due 
for CRC screening viewed a decision aid that uses words only (Verbal arm) vs. one that provides 
quantitative information (Quantitative arm).  Main outcomes included perceived CRC risk, 
intent to be screened, and test preference, measured before and after viewing decision aid, and 
screening uptake at six months.  Analyses were performed with ANCOVA and logistic 
regression. 
 
Results: Compared to the Verbal arm, those in the Quantitative arm had a larger increase in 
intent to undergo FIT (p=0.011) and were more likely to switch their preferred test from non-
FIT to FIT (28% vs. 19%, p=.010).  There were decreases in perceived risk in the Verbal Arm but 
not the Quantitative Arm (p=0.004).  There was no difference in screening uptake.  Numeracy 
did not mediate any effects.   
 
Conclusions:  Quantitative information had relatively minor impact and no clearly negative 
effects, such as reducing uptake. 
 
Practice Implications:  Quantitative information may be useful but not essential for patients 
viewing decision aids. 
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1. Introduction 
Guidelines for the design of decision aids recommend disclosure of quantitative 
information such as, for screening tests, baseline risk of the condition, risk reduction provided 
by the intervention, positive and negative predictive values, and chance of negative outcomes 
[1, 2].  Quantitative information may support informed decision making by increasing patient 
understanding [3, 4].  Quantitative information may not help all patients, however, especially 
those with limited numeracy skills [5, 6].  No well-powered randomized trial has measured the 
impact of disclosing the recommended types of quantitative information [7]. Heuristics and 
biases in human thought produce irrational responses to risk data including people’s tendency 
to underestimate the risk of a bad outcome (“optimism bias”) [8, 9].  It would be unfortunate if 
disclosing quantitative information triggered heuristics or biases that reduced uptake of 
preventive measures that save lives [10-14]. 
In this study, we compared the effects of verbal information and quantitative 
information in a decision aid for colorectal cancer (CRC) screening.  Screening is recommended 
for people ages 50-75 years old, and for those at average risk, several tests are recommended 
[15, 16].  Colonoscopy is the most commonly performed screening test and provides the most 
complete examination of the colon, but it has risks and requires a rigorous bowel prep [15-17].  
The second most common approach is annual stool blood testing, e.g. the fecal 
immunochemical test (FIT), which is easy to do and is performed at home [15-17].  A single 
application of FIT often fails to identify polyps and may miss a cancer, however, and a positive 
stool test requires colonoscopic evaluation.  Lifetime risk reduction provided by regular FIT may 
be slightly less than that provided by regular colonoscopy, though there continues to be some 
uncertainty about the long-term effects [15, 18].  The choice between colonoscopy, FIT, and 
other approved tests is “preference sensitive,” resulting in the creation and testing of several 
decision aids [7].  
The aims of the current study were to: 1) compare the impact of verbal information and 
quantitative information on outcomes of perceived CRC risk, CRC screening intent, colonoscopy 
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 intent, FIT intent, perceived benefits and barriers for colonoscopy and FIT, decision conflict, test 
choice (colonoscopy or FIT), and 6-month uptake of screening;  and 2) determine whether 
numeracy moderates any of these effects. 
 
2. METHODS 
 
2.1  Study Setting 
 The study was conducted from June 2015 to June 2017 at 18 primary care sites in the 
Indiana University Health (IUH) and 6 primary care sites of the Eskenazi Health (EH) system in 
central Indiana. The study was approved by the Indiana University Institutional Review Board 
prior to data collection and is registered with ClinicalTrials.gov (NCT02477553).  
 
2.2  Inclusion and Exclusion Criteria 
 Participants were screening-eligible male and female adults, 50-75 years old, who were 
scheduled or due to be seen by their primary care provider at participating clinics. Participants 
were eligible if they were not up-to-date with screening. We excluded patients who had: (1) a 
personal history of CRC, (2) inflammatory bowel disease or other condition or family history 
conferring elevated risk for CRC, (3) symptoms consistent with CRC, (4) difficulty reading 
English, or (5) been told by their provider to avoid CRC screening.  
 
2.3  Recruitment Process 
 Physician approval was obtained prior to contacting patients who appeared to be 
eligible based on electronic health record (EHR) review. Of 80 physicians approached, 70 (88%) 
agreed to have their patients contacted. Patients were sent an introductory letter and then 
contacted by phone to explain the study and assess eligibility. Eligible patients who agreed to 
participate met with a research assistant for approximately 1 hour, often immediately 
preceding a provider appointment.    
 
2.4  Study Procedure  
AC
CE
PT
ED
 M
AN
US
CR
IPT
 After confirming eligibility and providing written informed consent, participants were 
randomly assigned, using the REDCap database, to view the verbal decision aid (verbal group) 
or the quantitative decision aid (quantitative group).  Stratification was based on age (≤ 65 
years old or > 65 years old), gender (male, female), and health system. 
Data were collected and managed using REDCap electronic data capture tools hosted at 
Indiana University [19].  Participants  completed a baseline survey (T0) in REDCap using either a 
laptop computer or a paper version in the presence of a research assistant.  They then viewed 
the decision aid to which they were assigned, and completed a self-administered survey post-
intervention (T1). Six months later, participants were contacted by phone to complete a third 
interview (data not presented in this paper), and participants’ EHR data were checked for 
completion of a colonoscopy, FIT, or other approved screening test within six months of 
enrollment.  
 
2.5  Decision Aids 
 Both decision aids consisted of PowerPoint slides with text, photos, and an audio track, 
viewed on a laptop controlled by the participant.  The decision aids began with a 4½ min slightly 
edited version of a video on CRC screening produced by the American Cancer Society [20], 
followed by 3 slides summarizing the advantages and disadvantages of colonoscopy and stool 
testing with the fecal immunochemical test (FIT).   
 The quantitative decision aid explained the following quantitative information regarding 
CRC and the comparative effectiveness of colonoscopy and FIT, generally presented as 
frequencies depicted on icon charts:   
 Sensitivity of a single application of FIT and colonoscopy for CRC,  
 Average lifetime CRC incidence and mortality with no screening and with regular 
screening with colonoscopy or FIT (depicted individually on icon charts and jointly on a 
bar chart),  
 Frequency of a single FIT turning positive, and  
 Frequency of complication from a colonoscopy (hemorrhage or perforation).   
AC
CE
PT
ED
 M
AN
US
CR
IPT
 The verbal decision aid discussed each of these topics but used verbal descriptions only (“rare,” 
“reduced,” etc.) instead of numbers.  Both decision aids used only verbal descriptions of the 
sensitivity of colonoscopy and FIT for polyps and the frequency of FIT yielding a false positive, 
i.e. negative colonoscopy after positive FIT.  Appendix Table 1 lists the specific numbers and 
quantities disclosed in both decision aids.  Decisions about which numbers to present and 
which terms to use in the decision aids were guided by recommendations from the 
International Patient Decision Aids Standards Collaboration (IPDAS) [1, 21] and discussions with  
the research team, patient advisory board, and community advisory board.   
   The decision aids were updated from versions used in a pilot study [22] by the research 
team that included experts in health communication, gastroenterology, epidemiology, risk 
communication, biostatistics, and bioethics.  Scripts and visuals were circulated and discussed 
in biweekly meetings, and draft versions of the DAs were presented to patients and community 
members for assessment of acceptability, understandability, and satisfaction.  
 
2.6  Measures   
 Perceived Risk of CRC (T0, T1).  Perceived personal risk of CRC was assessed by asking 
participants how likely they were to get colon cancer during their lifetime, in the next 10 
years, and in the next 5 years. Each had response options: very likely, somewhat likely, 
somewhat unlikely, and very unlikely.  Perceived comparative risk of CRC was measured 
with a single item assessing “compared to other women/men your same age, would you say 
your change of getting colon cancer in the next 10 years is higher, about the same, lower, or 
don’t know.” 
 Benefits and Barriers (T0, T1). Perceived benefits and barriers were measured for 
colonoscopy and FIT separately using scales developed by our team [23]. All scales had 
Likert-type response options where 1=strongly agree to 5=strongly disagree.  
 Screening Intent; FIT Intent; Colonoscopy Intent (T0, T1).  Intent to be screened for CRC with 
any test (“Screening Intent”), intent to undergo FIT (“FIT Intent”), and intent to undergo 
colonoscopy (“Colonoscopy Intent”) were measured with 3 separate items: “Do you plan to 
get a [colon test/ stool test/ colonoscopy] within the next 6 months?” Each had response 
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 options of: 5=Definitely, 4=Probably, 3=May or May not, 2=Probably not, and 1=Definitely 
not.  
 Test Choice (T0, T1).  For those who answered the Screening Intent question – “Do you plan 
to get a colon test within the next 6 months?” with Definitely not, Probably not, or May or 
may not, Test Choice was categorized as “No screening.”  Those who answered the 
Screening Intent question with Probably or Definitely had their Test Choice categorized 
based on their answer to a single item:  “If you have a colon test, which one would you 
choose?” Response options were: FIT, Colonoscopy, Other, or Don’t know.  
 Decision Conflict (T0, T1). Decision conflict was assessed using the Decision Conflict Scale, a 
16-item instrument [24]. 
 Numeracy. Subjective numeracy was assessed with the Subjective Numeracy Scale (SNS) at 
T0 [25, 26].  Objective numeracy was measured with the short 8-item Numeracy 
Understanding in Medicine Instrument (NUMi) at T1 [27, 28]. 
 Health Literacy (T1). Health literacy was assessed using a 3-item health literacy scale [29]. 
 Uptake. Screening uptake was determined by documentation of a completed screening test 
within 6 months of enrollment in the participants’ EHR.  
 
2.7  Statistical Analysis:   
The sample size was based on results of our pilot study of a similar decision aid that 
showed overall CRC screening rates differed by 12% between the control and quantitative 
groups (26.9% vs 39.3%) [22].  To detect a similar difference in this study with 80% power with 
a chi-square test (α= 0.05), a sample size of 241 per group (482 total) was required.   To 
examine the moderating effect of numeracy, the required sample size was based on 
calculations provided in Demidenko (2008) [30] for detecting an interaction between two 
binary covariates (intervention group and numeracy) in a logistic regression model.  In this case, 
a total of 600 (300 per group) were required to have 80% power (α=0.05) to detect an 
interaction OR of 3.2, which was similar to the interaction OR estimated from our preliminary 
data of 3.7.  Thus, to have sufficient power for both aims, targeted enrollment was 600 
patients. 
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 All analyses were conducted using SAS Version 9.4 (Cary, NC) and the significance level 
set to α = 0.05 for all statistical tests.  Demographic information was summarized by 
frequencies and percents for categorical variables or by mean and standard deviation (SD) for 
continuous variables.  Group differences for categorical variables were compared with the Chi 
Square test or Fisher’s Exact test.  Continuous variables were compared using two-sample t-
tests.   
All models included covariates for site (Eskenazi or IU), gender and age (<=65 years and 
> 65 years) [31].  For aim 1, changes in perceived risk, screening intent, colonoscopy intent, FIT 
intent, benefits and barriers of colonoscopy and FIT, and decision conflict from baseline (T0) to 
post-intervention (T1) were compared between  groups using ANCOVA with baseline scores 
treated as covariates.  To check for changes in scores over time (i.e., assuming no interactions 
or main effects for group or numeracy), an intercept only model was used.  Test choice was 
examined before and after intervention to see if there was a change in 1) intent to be screened 
(Test Choice = No screening vs. Screening (with FIT, colonoscopy, other, or don’t know); and 2) 
Test Choice of something other than FIT at T0 (no screening, colonoscopy, other, or don’t know) 
to FIT at T1 and tested between groups using logistic regression. CRC screening rates were 
compared between the two groups using logistic regression. 
For aim 2, subjects were divided into two groups (above and below the median for total 
subjective numeracy and also for objective numeracy).  First, moderation was tested by adding 
a main effect for numeracy and group by numeracy interaction term to the models used in aim 
1.  If the interaction term was not significant, it was removed from the model and the main 
effects model was used.  
 
3.  Results: 
A total of 728 patients were randomized to quantitative (n=364) or verbal (n=364) 
groups (Figure 1). Forty patients were later excluded, resulting in sample sizes of 344 in each 
group. Mean age was 59 [s.d.=7] years. Most participants were white and 60% were female. 
Except for employment status, there were no statistically significant differences in demographic 
variables between the groups (Table 1). Thus, employment status was a covariate in models.   
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3.1  Perceived Risk, Screening Intent, Benefits, Barriers, and Decision Conflict  
Appendix Figures 1 and 2 show changes in perceived risk, CRC screening intent, others 
from baseline (T0) to immediately post-intervention (T1). There were statistically significant 
increases in CRC screening intent, FIT intent, perceived benefits of FIT and colonoscopy, and 
significant decreases for decision conflict and perceived barriers for FIT and colonoscopy (p < 
0.001) from T0 to T1 for both groups. There were no significant changes from T0 to T1 in 
perceived comparative risk, perceived personal risk, or colonoscopy intent.  
As shown in Table 2, there were no group differences for changes in perceived 
comparative risk, CRC screening intent, colonoscopy intent, benefits or barriers for either 
colonoscopy or FIT, or decision conflict.  Participants in the quantitative group had greater 
increases in FIT Intent (p=0.007) and perceived personal risk (p < .001) compared to the verbal 
group.   
 
3.2  Test Choice 
From T0 to T1, participants in both groups changed their test choice from ‘Do Not 
Intend to be Screened’ to one of the four screening options (colonoscopy, FIT, other, don’t 
know/missing) (Appendix Table 2). As shown in Table 3, the proportion that made this change 
was higher in the quantitative group (85/176 [48%]) compared to the verbal group (60/158 
[38%]; p=0.02).  A greater proportion of those in the quantitative group changed their test 
choice from non-FIT to FIT than the verbal group (29% vs 19%, p=0.005). 
 
3.3  Uptake 
At 6-months, CRC screening uptake in the EHR for all participants was 29%.  FIT uptake 
was 11%, and colonoscopy uptake was 19%, with no difference in uptake between groups 
(Table 4).  In the quantitative group, uptake of any CRC screening test was 29%, FIT was 11%, 
and colonoscopy was 19%.  In the verbal group, uptake of any CRC screening test was 30%, FIT 
was 11%, and colonoscopy was 20%. 
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 3.4  Effect of numeracy.   
Since we found the same substantive results for subjective and objective numeracy, we 
report the results for subjective numeracy only.  Although there were some main effects of 
numeracy, there were no significant interactions between group and subjective numeracy for 
perceived risk, screening intent, benefits, barriers, or decision conflict, thus no evidence of 
moderation (Table 5).   
 
4.  Discussion and Conclusion: 
 
4.1 Discussion 
This study found that including quantitative information in a decision aid significantly 
increased intent to undergo FIT but not colonoscopy for screening and increased perceived CRC 
risk but not comparative risk in patients eligible for screening.  Quantitative information had no 
impact on either uptake of screening or type of test at six months, and numeracy did not 
moderate the effect of quantitative information on any outcome.  Both decision aids increased 
intent to undergo screening and reduced decision conflict, in pre- to post-testing. 
Together, these findings help address concerns that quantitative information may have 
significant negative effects for patients overall, or for patients with limited numeracy skills.  At 
the same time, the findings show relatively limited impacts of including quantitative 
information and leave questions unanswered about whether such information should be 
included in all decision aids.  Since the study compared only one way of framing quantitative 
and verbal information about CRC screening, it cannot assess the impact of other methods of 
framing, or the impact of quantitative information on other medical decisions. 
The only previous randomized trial that we are aware of that compared decision aids 
that differed only in their inclusion of quantitative information was a pilot study we conducted. 
In our study,  223 patients who were due for CRC screening were randomized to view four 
different decision aids, two that  included quantitative information and two that did not [22].  
Findings in the current study extend those of our earlier study but differ in certain ways, which 
we discuss here. 
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 One concern about disclosing the specific baseline risk for a cancer in a decision aid has 
been that it would lower people’s perception of their risk which would lead to reduced intent 
and uptake of screening [10-12].  Another concern has been that disclosing the specific 
magnitude of absolute risk reduction provided by screening would reduce perceived benefit 
and, subsequently, reduce intent and uptake [10, 11].  The current study does not support 
either of these concerns.  While the change in perceived risk from T0 to T1 was significantly 
different for the two groups (p=.007), the changes were relatively small (+0.08 in the 
quantitative group and -0.08 in the verbal group, on a four-point scale) and, thus, have 
questionable clinical significance.  In our pilot study, individuals who viewed the quantitative 
information also had a small increase in perceived risk (+0.15 on a seven-point scale).  Changes 
in perceived benefit of colonoscopy or FIT did not differ between groups.   
The quantitative decision aid may have increased perceived risk, in part, by disclosing 
frequencies over a lifetime rather than a shorter time period, such as 5 or 10 years.  Incidence 
and mortality from cancer and the magnitude of absolute risk reduction provided by screening 
is higher over a lifetime than over shorter periods.   
Previous studies found that providing quantitative estimates of baseline risk of cancer 
leads to lower perceived risk, perhaps because people started with higher estimates of their 
risk.  When told their  baseline risk of getting breast cancer in their lifetime (approximately 13% 
on average), women in a previous study had reduced perceived risk, in part since they 
estimated their risk beforehand as much higher (25% or more in many cases) [32].  In another 
study, perceived risk of getting an upset stomach as a reaction to a medication was lower after 
the numeric frequency was disclosed (14,000 per 100,000), than when it was described as “very 
common” [33].  In that case, perceived risk may have been lower after viewing the numbers 
since the term “very common” was associated by many subjects with a higher probability than 
14%.  In our study, in contrast, the quantitative information presented in our decision aid 
regarding incidence and mortality of CRC may have generated an impression of these risks that 
was similar to the ones subjects developed when viewing the verbal decision aid. 
Viewing either the quantitative or verbal aid increased intent to undergo FIT, measured 
either as a response to a five-point Likert scale (“FIT Intent”) or as planned screening behavior 
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 (“Test choice”). The increase was greater for both outcomes in the quantitative group than in 
the verbal group.  Further, the changes in intent were clinically significant: the percent of 
patients choosing FIT as their test choice increased from T0 to T1 from 12% to 24% in the verbal 
group and from 11% to 34% in the quantitative group. These results match and extend findings 
from our pilot study, where mean FIT intent increased from T0 to T1 in both groups but the 
increase was significantly larger in the quantitative arm [22].  In the current study, the increase 
in selection of FIT as test choice resulted in an increase in intention to be screened overall that 
may be considered clinically significant (10% difference).  The higher test choice of FIT at T1 and 
of being screened overall in the quantitative arm, however, was not reflected in an increased 
uptake of FIT or of screening at 6 months.   
Viewing either decision aid resulted in a significant increase in patients’ intent to have 
FIT in part since many patients eligible for CRC screening do not know about alternative tests 
because many physicians offer only colonoscopy [34-36].  Our decision aids explain that stool 
testing is an approved alternative to colonoscopy, allowing patients to choose this non-invasive 
approach.  The quantitative decision aid may have resulted in a larger increase in FIT intent 
than the verbal decision aid because the numbers presented showed that the risk reduction 
provided by colonoscopy and FIT is similar: according to a leading model on which we based our 
presentation (SimCRC), colonoscopy reduces CRC mortality from 30 per 1000 to 4.6 per 1000, 
FIT reduces it to 6 per 1000 [37]. 
As mentioned previously, there is concern that disclosing quantitative information 
about baseline risk in a decision aid for screening would decrease perceived risk, and thus 
decrease uptake [10-12].  In this situation, there would be difficult questions about whether the 
goals of disclosure before screening should prioritize improved understanding (respecting 
individual autonomy) or increasing uptake of screening (improved health outcomes) [13], and 
whether the decrease in uptake reflected the action of heuristics or biases rather than patients’ 
informed preferences.  The current study found no decrease in uptake.  Our pilot study found 
that patients who viewed the quantitative decision aid had a significantly higher uptake of 
screening at six months than those who viewed the verbal decision aid [22], and we have no 
clear explanation for this difference in the studies.  
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 Our study has several notable strengths including that: 1) it was a randomized, 
controlled trial with a large sample size, fully powered for our primary outcomes; 2) patients 
were recruited from multiple clinics and were diverse in terms of race, income, and education; 
and 3) screening outcomes were measured using the EHR.  The main limitations are that it 
recruited only within a single city and surrounding area, and it was not powered for several 
secondary outcomes or for numeracy-moderating effects.  Although we measured knowledge, 
we will report those results, along with other measures of decision quality, subsequently.   
Finally, the study outcomes could have been impacted by the framing of words and 
numbers presented in the decision aids, a limitation that applies to any study involving decision 
aids.  As mentioned above, the increase in perceived risk seen with the quantitative decision aid 
may have been the result, at least in part, of the team’s decision to describe risk and risk 
reduction over a lifetime, rather than a shorter time period, such as 10 years. The magnitudes 
of predicted risk and risk reduction over a lifetime are larger and potentially more impressive 
than over shorter time frames.  As  another example, in keeping with recommendations, the 
decision aids described the sensitivity of a single application of FIT and of colonoscopy for CRC, 
using a frequency and icon graph in the quantitative arm and words in the verbal arm.  It is 
possible that viewers could overestimate the importance of a difference in sensitivity. For many 
patients, there may  be no negative consequence of FIT failing to identify a cancer or polyp on a 
single application, since many polyps do not progress to cancer and many polyps or cancers will 
be identified on later annual applications before they have progressed.  The decision aids 
included an explanation of why a missed polyp or cancer might not have a negative effect.  
Future research should further study the impact of message framing  in decision aids, building 
on the extensive body of research on framing [38]. 
 
4.2  Conclusion 
In conclusion, this study showed that including quantitative information in a decision aid 
regarding CRC screening had significant, if moderate, effects on patient perceptions and intent 
to undergo screening, specifically intent to undergo FIT.  The study did not show negative 
impacts on either intention or uptake of screening, and did not find large differences among 
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 patients with high and low numeracy.   Additional studies will be needed to determine the 
impact of other sorts of quantitative information, potentially framed in other ways, in decision 
aids.  
 
4.3 Practice Implications 
This study is the first adequately powered, randomized, controlled trial of the impact of 
quantitative information in a decision aid.   The findings provide some support for 
recommendations that decision aids should provide patients with quantitative information 
about risks and benefits of available options.  First, we did not find that quantitative 
information had negative consequences such as reducing uptake or negatively impacting 
decision-making of lower numeracy patients.  Second, we found that quantitative information 
had the clinically significant impact of increasing the percentage of patients selecting FIT as 
their preferred test.   
At the same time, these findings leave open the possibility that quantitative information 
should be an option for patients to view rather than a required part of decision aids.  Further 
discussion of the place of quantitative information in decision aids will need to take these 
findings into account. 
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 Figure 1 Study flow diagram 
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 Table 1:  Demographics by Group (Mean [SD] or n [%]) 
Category Value 
Verbal 
(N=344) 
Quantitative 
(N=344) 
 p-
value* 
Site 
Eskenazi 96 (28%) 93 (27%) 0.80 
IU Health 248 (72%) 251 (73%) 
Age  Mean (SD) 58.71 (6.49) 58.83 (6.66) 0.81 
Age - Categorical 
<=65 y/o 288 (84%) 283 (82%) 0.61 
>65 y/o 56 (16%) 61 (18%) 
Gender 
Female 206 (60%) 198 (58%) 0.54 
Male 138 (40%) 146 (42%) 
Race 
 
American Indian or Alaskan 
Native 
1 (0%) 1 (0%) 0.106 
Asian 3 (1%) 4 (1%) 
Black or African American 98 (28%) 86 (25%) 
Missing 12 (3%) 10 (3%) 
Multiple 16 (5%) 5 (1%) 
Native Hawaiian or Pacific 
Islander 
1 (0%) 1 (0%) 
Other race 8 (2%) 5 (1%) 
White 205 (60%) 232 (67%) 
Ethnicity - Hispanic/Latino 
Yes 12 (3%) 5 (1%) 0.112 
No 317 (92%) 329 (96%) 
Do not know 4 (1%) 1 (0%) 
Missing 11 (3%) 9 (3%) 
Education 
Less than high school 25 (7%) 15 (4%) 0.38 
High school graduate/GED 75 (22%) 89 (26%) 
Some college/technical 
school/trade school 
92 (27%) 80 (23%) 
Associate’s degree school 35 (10%) 31 (9%) 
Bachelor’s degree 58 (17%) 68 (20%) 
Professional or graduate 
degree 
44 (13%) 51 (15%) 
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 Category Value 
Verbal 
(N=344) 
Quantitative 
(N=344) 
 p-
value* 
Don’t Know 2 (1%) 1 (0%) 
Missing 13 (4%) 9 (3%) 
Relationship 
Single 71 (21%) 75 (22%) 0.21 
Married/living with partner 170 (49%) 168 (49%) 
Separated 12 (3%) 10 (3%) 
Divorced 61 (18%) 73 (21%) 
Widowed 19 (6%) 8 (2%) 
Missing 11 (3%) 10 (3%) 
Employed? 
Yes 158 (46%) 188 (55%) 0.037 
No 170 (49%) 146 (42%) 
Missing 16 (5%) 10 (3%) 
Health Insurance? 
Yes 315 (92%) 317 (92%) 0.49 
No 13 (4%) 17 (5%) 
Missing 16 (5%) 10 (3%) 
Income Level Subjective 
Are comfortable 129 (38%) 145 (42%) 0.113 
Have just enough to make 
ends meet 
117 (34%) 125 (36%) 
Do NOT have enough to 
make ends meet 
80 (23%) 59 (17%) 
Missing 18 (5%) 15 (4%) 
Ever heard of FIT? 
Yes 234 (68%) 242 (70%) 0.86 
No 78 (23%) 78 (23%) 
Missing 32 (9%) 24 (7%) 
Ever heard of Colonoscopy? 
Yes 295 (86%) 312 (91%) 0.094 
No 17 (5%) 9 (3%) 
Missing 32 (9%) 23 (7%) 
Doctor ever recommend 
colon test? 
Yes 190 (55%) 206 ( 60%) 0.64 
No 105 (31%) 105 (31%) 
Do not know 16 (5%) 10 (3%) 
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 Category Value 
Verbal 
(N=344) 
Quantitative 
(N=344) 
 p-
value* 
Missing 33 (10%) 23 (7%) 
Doctor ever recommend 
colonoscopy? 
Yes 172 (50%) 179 (52%) 0.88 
No 121 (35%) 129 ( 38%) 
Do not know 16 (5%) 13 (4%) 
Missing 35 (10%) 23 (7%) 
Doctor ever recommend FIT 
test? 
Yes 88 (26%) 101 (29%) 0.39 
No 200 (58%) 197 (57%) 
Do not know 21 (6%) 21 (6%) 
Missing 35 (10%) 25 (7%) 
*p-value from t-test, Chi-Square, or Fisher’s Exact Test, where appropriate. Missing and Do not know 
were not included in analysis. 
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 Table 2: Between-Group Differences in Change in Perceived Risk, Intent, Benefits, Barriers, and 
Decision Conflict 
 
Variable  Group 
Change (T1 – T0) 
N, Mean (SD) 
Intervention Effect 
Estimate (95% CI)** 
 
p-value* 
Perceived Comparative Risk 
Verbal 217,  -0.04 (0.45) 0.06 (-0.02, 0.14) 0.173 
Quantitative 232, 0.05 (0.52) 
Perceived Personal Risk  
Verbal 333, -0.08 (0.70) 0.16 (0.07, 0.26) <0.001 
Quantitative 336,  0.08 (0.81) 
CRC Screening Intent 
Verbal 342,  0.37 (0.84) 0.09 (-0.03, 0.20) 0.142 
Quantitative 342,  0.47 (0.84) 
Colonoscopy Intent 
Verbal 341,  0.03 (0.81) 0.03 (-0.09, 0.14) 0.66 
Quantitative 338,  0.06 (0.80) 
FIT Intent 
Verbal 341,  0.26 (1.13) 0.22 (0.06, 0.37) 0.007 
Quantitative 338,  0.46 (1.09) 
Colonoscopy Benefits 
Verbal 324, 0.44 (0.62) 0.03 (-0.05, 0.11) 0.47 
Quantitative 332, 0.47 (0.62) 
FIT Benefits 
Verbal 320, 0.44 (0.76) 0.07 (-0.02, 0.17) 0.138 
Quantitative 330, 0.52 (0.73) 
Colonoscopy Barriers 
Verbal 322,  -0.18 (0.47) 0.05 (-0.02, 0.12) 0.149 
Quantitative 330,  -0.13 (0.45) 
FIT Barriers 
Verbal 321,  -0.18 (0.55) -0.01 (-0.09, 0.07) 0.74 
Quantitative 327,  -0.21 (0.54) 
Overall Decision Conflict Score 
Verbal 316, -19.3 (17.77) -0.12 (-1.95, 1.72) 0.90 
Quantitative 326, -22.0 (19.25) 
*p-value for Group from the model: T1 outcome=Group + T0 outcome + site + age + gender + 
employment 
**the Verbal Group is the reference group 
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 Table 3:  Change in Test Preference from T0 to T1 by Group, Overall and by Subjective 
Numeracy Level 
Group 
Change from not Screen to Screen  Change from not FIT to FIT  
Overall 
Low 
Subjective 
Numeracy 
High 
Subjective 
Numeracy 
Overall 
Low 
Subjective 
Numeracy 
High 
Subjective 
Numeracy 
Verbal  60/158 (38%) 34/77 (44%) 25/79 (32%) 56/301 
(19%) 
31/147 (21%) 24/149 (16%) 
Quantitative  85/176 (48%) 40/86 (47%) 44/88 (50%) 87/305 
(29%) 
42/140 (30%) 45/161 (28%) 
Final Model 
(Main Effects) 
p-values 
0.022 Arm: 0.020* 
Numeracy: 0.61 
0.005 Arm: 0.004* 
Numeracy: 0.48 
*All results are from the main effects model since the interaction Group*numeracy was not 
significant in any of the model 
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Table 4:  CRC Screening Uptake, Overall and by Group and Subjective Numeracy Level 
 
Variable 
Verbal 
n/N (%) 
Quantitative 
n/N (%) 
Final Model 
(Main Effects)  
p-values* 
Odds Ratio (95% CI) 
Overall 
CRC 
screening 
uptake 
99/332 (29.8%) 99/340 (29.1%) 
0.74 0.94 (0.67, 1.33) 
FIT uptake 36/332 (10.8%) 38/340 (11.2%) 0.96 1.01 (0.62, 1.67) 
Colonoscop
y uptake 
64/332 (19.3%) 63/340 (18.5%) 
0.72 0.93 (0.63, 1.38) 
Below 
Total 
Subjective 
Numeracy 
Median 
CRC 
screening 
uptake 
43/167 (25.6%) 34/158 (21.5%) 
Group: 0.70 
Numeracy: 
0.031 
Group: 0.94 (0.66, 
1.32) 
Numeracy: 1.48 (1.04, 
2.11) 
FIT uptake 15/167 (9.0%) 8/158 (5.1%) 
Group: 0.90 
Numeracy: 
0.013 
Group: 0.97 (0.58, 
1.61) 
Numeracy: 1.99 (1.16, 
3.40) 
Colonoscop
y uptake 
29/167 (17.4%) 26/158 (16.5%) 
Group: 0.78 
Numeracy: 0.57 
Group: 0.95 (0.63, 
1.41) 
Numeracy: 1.13 (0.75, 
1.69) 
Above 
Total 
Subjective 
Numeracy 
Median 
CRC 
screening 
uptake 
53/157 (33.8%) 63/175 (36.0%) 
  
FIT uptake 20/157 (12.7%) 29/175 (16.6%)   
Colonoscop
y uptake 
33/157 (22.0%) 36/175 (20.6%) 
  
n = number screened; N=Total N 
*overall: p-value for Group from the model: Uptake=Group + site + age + gender + employment 
 By numeracy: p-value for Group and numeracy from the model:  Uptake=Group + numeracy + 
site + age + gender + employment.  All results are from the main effects model since the 
interaction Group*numeracy was not significant in any of the models. 
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 Table 5:  Between-Group Differences in Change in Perceived Risk, Intent, Benefits, Barriers, and Decision Conflict 
by Subjective Numeracy (Above/Below the Median) 
Variable 
Subjective 
Numeracy 
Group 
Change (T1-T0) 
N, Mean (SD) 
Intervention Effect Estimate 
(95% CI)** 
Final Model 
(Main Effects) 
p-value* 
Perceived 
Comparative 
risk 
Low  
Verbal 94,  0.00 (0.46) Group: 0.06 (-0.02, 0.13) 
Numeracy: 0.14 (0.06, 0.22) 
Group: 0.169 
Numeracy: 0.001 Quantitative 98, 0.10 (0.55) 
High  
Verbal 121,  -0.07 (0.44) 
Quantitative 132, 0.01 (0.49) 
Perceived 
Personal risk  Low  
Verbal 169, -0.04 (0.77) Group: 0.17 (0.07, 0.26) 
Numeracy: 0.17 (0.07, 0.27) 
Group: <0.001 
Numeracy: <0.001 Quantitative 159,  0.15 (0.86) 
High 
Verbal 161, -0.14 (0.63) 
Quantitative 175,  0.03 (0.76) 
CRC Screening 
Intent Low  
Verbal 172,  0.38 (0.82) Group: 0.09 (-0.03, 0.20) 
Numeracy: -0.02 (-0.14, 0.10) 
Group: 0.137 
Numeracy: 0.70 Quantitative 160,  0.48 (0.88) 
High  
Verbal 164,  0.36 (0.88) 
Quantitative 177,  0.47 (0.81) 
Colonoscopy 
Intent Low  
Verbal 172,  0.05 (0.82) Group: 0.02 (-0.10, 0.14) 
Numeracy: 0.08 (-0.05, 0.20) 
Group: 0.74 
Numeracy: 0.23 Quantitative 158,  0.16 (0.80) 
High  
Verbal 164,  0.02 (0.80) 
Quantitative 176, -0.03 (0.79) 
FIT Intent 
Low  
Verbal 172,  0.21 (1.18) Group: 0.21 (0.05, 0.36) 
Numeracy: -0.03 (-0.19, 0.13) 
Group: 0.011 
Numeracy: 0.71 Quantitative 158,  0.49 (1.13) 
High  
Verbal 164,  0.34 (1.03) 
Quantitative 176,  0.45 (1.06) 
Colonoscopy 
Benefits Low  
Verbal 162, 0.40 (0.62) Group: 0.03 (-0.06, 0.11) 
Numeracy: -0.15 (-0.24, 0.07) 
Group: 0.53 
Numeracy: <0.001 Quantitative 156, 0.39 (0.60) 
High  
Verbal 161, 0.49 (0.61) 
Quantitative 174, 0.53 (0.64) 
FIT Benefits 
Low  
Verbal 159, 0.33 (0.68) Group: 0.07 (-0.03, 0.16) 
Numeracy: -0.19 (-0.29, -
0.09) 
Group: 0.172 
Numeracy: <0.001 Quantitative 156, 0.46 (0.75) 
High  
Verbal 160, 0.56 (0.81) 
Quantitative 173, 0.58 (0.71) 
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 Variable 
Subjective 
Numeracy 
Group 
Change (T1-T0) 
N, Mean (SD) 
Intervention Effect Estimate 
(95% CI)** 
Final Model 
(Main Effects) 
p-value* 
Colonoscopy 
Barriers Low  
Verbal 161,  -0.16 (0.46) Group: 0.05 (-0.02, 0.12) 
Numeracy: 0.01 (-0.06, 0.08) 
Group: 0.130 
Numeracy: 0.77 Quantitative 155,  -0.15 (0.48) 
High  
Verbal 160,  -0.19 (0.48) 
Quantitative 174,  -0.10 (0.42) 
FIT Barriers 
Low  
Verbal 160,  -0.17 (0.55) Group: -0.01 (-0.09, 0.07) 
Numeracy: 0.10 (0.02, 0.19) 
Group: 0.81 
Numeracy: 0.014 Quantitative 155,  -0.14 (0.57) 
High  
Verbal 160,  -0.20 (0.55) 
Quantitative 171,  -0.27 (0.50) 
Overall Conflict 
Score Low  
Verbal 159, -18.0 (17.80) Arm: -0.05 (-1.87, 1.76) 
Numeracy: 3.66 (1.79, 5.53) 
Arm: 0.95 
Numeracy: <0.001 Quantitative 154, -18.2 (17.59) 
High  
Verbal 157, -20.6 (17.71) 
Quantitative 172, -25.3 (20.08) 
*p-value from the model: T1 outcome =arm + numeracy + T0 outcome + site + age + gender + employment.  Only 
main effect models were used since arm*numeracy was not significant in any of the interaction models. 
**the Verbal arm and High Numeracy were the reference groups. 
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